The diagnosis of Alzheimer’s disease: an update and current controversies
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 6 December 2022
The chapter of the diagnosis of Alzheimer’s disease (AD), almost unchanged since the early 80’s, has been recognizing over the last years a revival of scientific and clinical interest, following increasing advances, and currently represents one of the main developing fields of neurological research. In this review we report the most recent evidence in the field, mainly based on the use of neurobiological markers of disease, as well as the current most debated issues, such as the impact of markers on the diagnostic workup and their incremental diagnostic value with respect to early diagnosis in typical cases and in those characterized by comorbidities or association with brain vascular pathology (mixed forms).
Downloads
How to Cite
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.